16p11.2 microduplication and associated symptoms: A case study

Martin Knoll, Kirsten Arnett, Jeremy Brandon Hertza

Research output: Contribution to journalArticle

Abstract

The minimal amount known regarding chromosomal microduplications and microdeletions presents a fascinating new direction of research into better understanding misunderstood symptoms and overall genomic influence. Specifically, the 16p11.2 microduplication has been associated with a myriad of possible cognitive, physical, and emotional symptoms. The purpose of this study is to inform the reader of the biological basis of the 16p11.2 microduplication, review sources that suggest a link between the microduplication and clinically relevant diagnoses/sources of impairment, and to better understand the implications and development of symptoms through the illustration of a case example. The case study involves an adolescent African-American female that possesses the 16p11.2 microduplication and focuses on the patient’s intellectual and developmental delays, seen through self-report and analysis of her neurocognitive assessment results. Additionally, the patient’s associated health complications, such as the development of seizures and a possibly compromised immune system, along with the development of anxiety and depression, are discussed. Implications toward the need for more robust protocol in testing and tracking the effects of this microduplication, such as implementing immunosorbent assay testing at the first sign of associated symptoms, are explored. Limitations are discussed.

LanguageEnglish (US)
Pages374-379
Number of pages6
JournalApplied Neuropsychology: Child
Volume7
Issue number4
DOIs
StatePublished - May 21 2018
Externally publishedYes

Fingerprint

Immunosorbents
African Americans
Self Report
Signs and Symptoms
Immune System
Seizures
Anxiety
Depression
Health
Research
Direction compound

Keywords

  • Case study
  • Cognition
  • Microduplication

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Developmental and Educational Psychology

Cite this

16p11.2 microduplication and associated symptoms : A case study. / Knoll, Martin; Arnett, Kirsten; Hertza, Jeremy Brandon.

In: Applied Neuropsychology: Child, Vol. 7, No. 4, 21.05.2018, p. 374-379.

Research output: Contribution to journalArticle

@article{5afe09e92811401daa21e01418d82f2c,
title = "16p11.2 microduplication and associated symptoms: A case study",
abstract = "The minimal amount known regarding chromosomal microduplications and microdeletions presents a fascinating new direction of research into better understanding misunderstood symptoms and overall genomic influence. Specifically, the 16p11.2 microduplication has been associated with a myriad of possible cognitive, physical, and emotional symptoms. The purpose of this study is to inform the reader of the biological basis of the 16p11.2 microduplication, review sources that suggest a link between the microduplication and clinically relevant diagnoses/sources of impairment, and to better understand the implications and development of symptoms through the illustration of a case example. The case study involves an adolescent African-American female that possesses the 16p11.2 microduplication and focuses on the patient’s intellectual and developmental delays, seen through self-report and analysis of her neurocognitive assessment results. Additionally, the patient’s associated health complications, such as the development of seizures and a possibly compromised immune system, along with the development of anxiety and depression, are discussed. Implications toward the need for more robust protocol in testing and tracking the effects of this microduplication, such as implementing immunosorbent assay testing at the first sign of associated symptoms, are explored. Limitations are discussed.",
keywords = "Case study, Cognition, Microduplication",
author = "Martin Knoll and Kirsten Arnett and Hertza, {Jeremy Brandon}",
year = "2018",
month = "5",
day = "21",
doi = "10.1080/21622965.2017.1326046",
language = "English (US)",
volume = "7",
pages = "374--379",
journal = "Applied Neuropsychology: Child",
issn = "2162-2965",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - 16p11.2 microduplication and associated symptoms

T2 - Applied Neuropsychology: Child

AU - Knoll, Martin

AU - Arnett, Kirsten

AU - Hertza, Jeremy Brandon

PY - 2018/5/21

Y1 - 2018/5/21

N2 - The minimal amount known regarding chromosomal microduplications and microdeletions presents a fascinating new direction of research into better understanding misunderstood symptoms and overall genomic influence. Specifically, the 16p11.2 microduplication has been associated with a myriad of possible cognitive, physical, and emotional symptoms. The purpose of this study is to inform the reader of the biological basis of the 16p11.2 microduplication, review sources that suggest a link between the microduplication and clinically relevant diagnoses/sources of impairment, and to better understand the implications and development of symptoms through the illustration of a case example. The case study involves an adolescent African-American female that possesses the 16p11.2 microduplication and focuses on the patient’s intellectual and developmental delays, seen through self-report and analysis of her neurocognitive assessment results. Additionally, the patient’s associated health complications, such as the development of seizures and a possibly compromised immune system, along with the development of anxiety and depression, are discussed. Implications toward the need for more robust protocol in testing and tracking the effects of this microduplication, such as implementing immunosorbent assay testing at the first sign of associated symptoms, are explored. Limitations are discussed.

AB - The minimal amount known regarding chromosomal microduplications and microdeletions presents a fascinating new direction of research into better understanding misunderstood symptoms and overall genomic influence. Specifically, the 16p11.2 microduplication has been associated with a myriad of possible cognitive, physical, and emotional symptoms. The purpose of this study is to inform the reader of the biological basis of the 16p11.2 microduplication, review sources that suggest a link between the microduplication and clinically relevant diagnoses/sources of impairment, and to better understand the implications and development of symptoms through the illustration of a case example. The case study involves an adolescent African-American female that possesses the 16p11.2 microduplication and focuses on the patient’s intellectual and developmental delays, seen through self-report and analysis of her neurocognitive assessment results. Additionally, the patient’s associated health complications, such as the development of seizures and a possibly compromised immune system, along with the development of anxiety and depression, are discussed. Implications toward the need for more robust protocol in testing and tracking the effects of this microduplication, such as implementing immunosorbent assay testing at the first sign of associated symptoms, are explored. Limitations are discussed.

KW - Case study

KW - Cognition

KW - Microduplication

UR - http://www.scopus.com/inward/record.url?scp=85019613843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019613843&partnerID=8YFLogxK

U2 - 10.1080/21622965.2017.1326046

DO - 10.1080/21622965.2017.1326046

M3 - Article

VL - 7

SP - 374

EP - 379

JO - Applied Neuropsychology: Child

JF - Applied Neuropsychology: Child

SN - 2162-2965

IS - 4

ER -